title: Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor.
authors.affiliation: Merck Research Laboratories, P.O. Box 4, WP75B-100, West Point, PA 19486, USA. arthur_bergman@merck.com
authors.forename: Arthur J
authors.initials: AJ
authors.lastname: Bergman
authors.forename: Josee
authors.initials: J
authors.lastname: Cote
authors.forename: Bingming
authors.initials: B
authors.lastname: Yi
authors.forename: Thomas
authors.initials: T
authors.lastname: Marbury
authors.forename: Suzanne K
authors.initials: SK
authors.lastname: Swan
authors.forename: William
authors.initials: W
authors.lastname: Smith
authors.forename: Keith
authors.initials: K
authors.lastname: Gottesdiener
authors.forename: John
authors.initials: J
authors.lastname: Wagner
authors.forename: Gary A
authors.initials: GA
authors.lastname: Herman
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000493:pharmacokinetics*; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000493:pharmacokinetics*; D051437:Renal Insufficiency / Q000209:etiology / Q000503:physiopathology*; D000068900:Sitagliptin Phosphate; D014230:Triazoles / Q000493:pharmacokinetics*
chemical_list: D004791:Enzyme Inhibitors; D007004:Hypoglycemic Agents; D011719:Pyrazines; D014230:Triazoles; D000068900:Sitagliptin Phosphate